Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MindSet Rx is a personalized medicine company dedicated to improving mental health outcomes through pharmacogenetic (PGx) testing and clinical decision support. The company's platform analyzes a patient's unique genetic profile to predict how they will respond to various psychiatric medications, including antidepressants, antipsychotics, and stimulants. By identifying genetic variations in key drug-metabolizing enzymes and neurotransmitter receptors, MindSet Rx provides clinicians with actionable insights to reduce the trial-and-error process often associated with behavioral health treatments. Their mission is to help patients find the right medication and dosage more quickly while minimizing the risk of adverse side effects. The company integrates genetic data with evidence-based clinical guidelines to optimize treatment plans for conditions such as depression, anxiety, and ADHD.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MindSet Rx.